| Date Filed | Type | Description |
| 05/03/2019 |
GN
| SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Charles River Laboratories International, Inc. - CRL |
| 05/02/2019 |
GN
| Bragar Eagel & Squire, P.C. is Investigating Charles River Laboratories International, Inc. (CRL) on Behalf of Stockholders and Encourages CRL Investors to Contact the Firm |
| 03/25/2019 |
GN
| Report: Developing Opportunities within Bristol-Myers Squibb, AutoNation, FirstEnergy, Charles River Laboratories International, Yum! Brands, and AGNC Investment — Future Expectations, Projections Moving into 2019 |
| 01/18/2019 |
GN
| Consolidated Research: 2019 Summary Expectations for Electronic Arts, Charles River Laboratories International, Cooper-Standard, Five Below, Emerge Energy Services LP, and Hornbeck Offshore Services — Fundamental Analysis, Key Performance Indications |
| 05/10/2018 |
BW
| Charles River Laboratories Announces First-Quarter 2018 Results from Continuing Operations |
| 04/20/2018 |
GN
| New Research Coverage Highlights MPLX LP, TESARO, LKQ, Cytokinetics, Keysight Technologies, and Charles River Laboratories International — Consolidated Revenues, Company Growth, and Expectations for 2018 |
| 04/12/2018 |
BW
| Charles River Laboratories Schedules First-Quarter 2018 Earnings Release and Conference Call |
| 02/16/2018 |
GN
| Market Trends Toward New Normal in Tile Shop Holdings, Cytokinetics, Limelight Networks, CatchMark Timber Trust, Global Payments, and Charles River Laboratories International — Emerging Consolidated Expectations, Analyst Ratings |
| 02/13/2018 |
BW
| Charles River Laboratories Announces Fourth-Quarter and Full-Year 2017 Results from Continuing Operations and Provides 2018 Guidance |
| 01/25/2018 |
BW
| Charles River Laboratories Schedules Fourth-Quarter 2017 Earnings and 2018 Guidance Release and Conference Call |
| 11/09/2017 |
BW
| Charles River Laboratories Announces Third-Quarter 2017 Results from Continuing Operations |
| 10/12/2017 |
BW
| Charles River Laboratories Changes the Date of Its Third-Quarter 2017 Earnings Release and Conference Call |
| 10/11/2017 |
BW
| Charles River Laboratories Schedules Third-Quarter 2017 Earnings Release and Conference Call |
| 09/05/2017 |
BW
| Charles River Laboratories to Present at September Investor Conferences |
| 08/09/2017 |
BW
| Charles River Laboratories Announces Second-Quarter 2017 Results from Continuing Operations |
| 07/13/2017 |
BW
| Charles River Laboratories Schedules Second-Quarter 2017 Earnings Release and Conference Call |
| 06/05/2017 |
BW
| Charles River Laboratories to Present at Jefferies Global Healthcare Conference |
| 05/10/2017 |
BW
| Charles River Laboratories Announces First-Quarter 2017 Results from Continuing Operations |
| 04/12/2017 |
BW
| Charles River Laboratories Schedules First-Quarter 2017 Earnings Release and Conference Call |
| 03/06/2017 |
BW
| Charles River Laboratories to Present at Raymond James and Barclays Conferences |
| 02/14/2017 |
BW
| Charles River Laboratories Announces Fourth-Quarter and Full-Year 2016 Results from Continuing Operations and Provides 2017 Guidance |
| 02/09/2017 |
BW
| Charles River Laboratories Changes Time of Fourth-Quarter 2016 Earnings and 2017 Guidance Conference Call |
| 07/12/2011 |
PRN
| The Alzheimer's Drug Discovery Foundation and Charles River Collaborate to Create a New Cognitive Aging Research Program |
| 06/06/2011 |
BW
| Charles River to Present at June Investor Conferences |
| 05/09/2011 |
BW
| Charles River to Present at Bank of America Merrill Lynch Health Care Conference |
| 05/03/2011 |
BW
| Charles River Announces First-Quarter 2011 Results from Continuing Operations |
| 03/03/2011 |
BW
| Charles River Announces Agreement to Supply Pfizer's Genetically Modified Research Models |
| 02/24/2011 |
BW
| Charles River Implements $150 Million Accelerated Stock Repurchase Program |
| 12/14/2010 |
BW
| Charles River Discusses Business Outlook with Investors |
| 11/11/2010 |
BW
| Charles River Schedules 2011 Guidance Release and Conference Call |
| 11/03/2010 |
BW
| Charles River Announces Third-Quarter 2010 Results |
| 10/13/2010 |
BW
| Charles River Announces Exclusive License with Transposagen Biopharmaceuticals, Inc. |
| 10/04/2010 |
BW
| Charles River Schedules Third-Quarter 2010 Earnings Release and Conference Call |
| 09/13/2010 |
BW
| Charles River to Present at Morgan Stanley and UBS Conferences |
|